Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Børsurougen | Sundhed & Vækst og M&A 8.9.2026

Analyst Comment09.09.2026, 06.35
Inderes

Summary

  • Arrangementet "Børsurougen" den 8.9.2026 fokuserer på investeringer inden for sundhed og vækst samt M&A, med præsentationer fra ledere i virksomheder som Aiforia, Terveystalo, Orion, Relais og Aspo.
  • Programmet inkluderer introduktioner og dybdegående analyser af investeringsmuligheder fra ledende figurer som Jukka Tapaninen, Juuso Pajunen og Rolf Jansson.
  • Alle præsentationer kan ses live på inderesTV og er tilgængelige som optagelser, hvilket giver investorer mulighed for at få indsigt i forskellige sektorer gennem ugen.

Dette indhold er genereret af AI. Du kan give feedback om det på Inderes forum.

Automatisk oversættelse: Oprindeligt udgivet på finsk 9.9.2026, 04.35 GMT. Giv feedback her.

PROGRAM FOR TIRSDAG DEN 8.9.2026:

Børsinvestorens uge | Sundhedssektoren

  • Velkommen! Introduktion til dagens tema: Savanna Saarikko, Jyri Tuominen & Antti Siltanen (link)
  • Aiforia som investering: Jukka Tapaninen, adm. direktør, Aifora Technologies (link)
  • Terveystalo som investering: Juuso Pajunen, CFO, Terveystalo (link)
  • Orion Pharma som investering: Tuukka Hirvonen, Head of Investor Relations, Orion Pharma (link)

Børsinvestorens uge | Vækst og Virksomhedsopkøb

  • Velkommen! Introduktion til dagens tema: Antti Mustonen, Savanna Saarikko & Kasper Mellas (link)
  • Relais som investering: Christian Gebauer, adm. direktør, Relais (link)
  • Aspo som investering: Rolf Jansson, adm. direktør, Aspo (link)

...Alle ugens præsentationer kan ses live på inderesTV og senere som optagelse:

MANDAG DEN 7.9.2026Finans

TIRSDAG DEN 8.9.2026Sundhedssektoren & Vækst og Virksomhedsopkøb

ONSDAG DEN 9.9.2026Medie & Teknologi

TORSDAG DEN 10.9.2026Forbrugere og Handel

FREDAG DEN 11.9.2026Industri & Ingeniørvirksomheder

MANDAG DEN 14.9.2026Ekstradag

Stay up to date
Aiforia Technologies
Terveystalo
Orion
Relais Group
Aspo

Forum discussions

In my opinion, the CEO holds their own quite well in this panel. Sure, this industry is still pretty much in its infancy, but before you know...
10/1/2026, 11:52 AM
by Salvelinus
12
Näytti Zeroman Oy hypänneen myös Aiforian kelkkaan ja Laakkonen lisänneen reippaasti,kai nämä voi laskea positiivisiksi merkeiksi.
10/1/2026, 4:39 AM
by Salvelinus
12
Sectra has a large number of partners. Aiforia is just one of them. To my knowledge, Aiforia hasn’t announced the conquest of that region in...
9/21/2026, 1:39 PM
by Vino Pino
9
https://www.pathologynews.com/french-region-goes-live-with-digital-pathology-from-sectra-to-speed-up-cancer-diagnostics/ So, has the platform...
9/21/2026, 12:36 PM
by tthombs
6
It’s strange that a 160k euro trade makes the news…
9/17/2026, 9:02 PM
by JusaVaan
0
Someone wanted to get rid of them, but someone else was happy to take them, doesn’t directly match anyone’s holdings. From Kauppalehti’s breaking...
9/17/2026, 3:24 PM
by NukkeNukuttaja
13
LinkedIn Home - 2026 World Medical Innovation Forum | Aiforia Technologies Aiforia's CEO, Jukka Tapaninen, will be speaking on an expert panel...
9/17/2026, 10:22 AM
by Salvelinus
17